Nordea Investment Management
BMRN icon

Nordea Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Nordea Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.55M Buy
114,953
+1,051
+0.9% +$57.6K 0.01% 552
2026
Q1 		$6.32M Buy
+113,902
New +$6.64M 0.01% 537
2025
Q4 		– Sell
-18,679
Closed -$995K – 863
2025
Q3 		$995K Buy
18,679
+3,735
+25% +$214K ﹤0.01% 816
2025
Q2 		$819K Buy
14,944
+66
+0.4% +$3.89K ﹤0.01% 836
2025
Q1 		$1.05M Buy
14,878
+56
+0.4% +$3.77K ﹤0.01% 800
2024
Q4 		$977K Hold
14,822
– – ﹤0.01% 812
2024
Q3 		$1.04M Sell
14,822
-30
-0.2% -$2.51K ﹤0.01% 800
2024
Q2 		$1.24M Buy
14,852
+1,177
+9% +$98K ﹤0.01% 779
2024
Q1 		$1.21M Buy
13,675
+2,081
+18% +$186K ﹤0.01% 793
2023
Q4 		$1.12M Buy
11,594
+544
+5% +$48.1K ﹤0.01% 805
2023
Q3 		$983K Sell
11,050
-521
-5% -$46.4K ﹤0.01% 810
2023
Q2 		$1.05M Hold
11,571
– – ﹤0.01% 800
2023
Q1 		$1.12M Hold
11,571
– – ﹤0.01% 767
2022
Q4 		$1.18M Hold
11,571
– – ﹤0.01% 743
2022
Q3 		$996K Buy
11,571
+581
+5% +$51.7K ﹤0.01% 778
2022
Q2 		$906K Buy
10,990
+2,362
+27% +$188K ﹤0.01% 808
2022
Q1 		$668K Hold
8,628
– – ﹤0.01% 860
2021
Q4 		$772K Hold
8,628
– – ﹤0.01% 853
2021
Q3 		$666K Hold
8,628
– – ﹤0.01% 884
2021
Q2 		$720K Hold
8,628
– – ﹤0.01% 863
2021
Q1 		$656K Hold
8,628
– – ﹤0.01% 855
2020
Q4 		$757K Buy
8,628
+948
+12% +$75.2K ﹤0.01% 798
2020
Q3 		$590K Sell
7,680
-7,680
-50% -$777K ﹤0.01% 793
2020
Q2 		$1.89M Buy
15,360
+7,680
+100% +$763K ﹤0.01% 722
2020
Q1 		$634K Buy
7,680
+383
+5% +$33K ﹤0.01% 763
2019
Q4 		$615K Hold
7,297
– – ﹤0.01% 809
2019
Q3 		$497K Buy
7,297
+657
+10% +$50.6K ﹤0.01% 846
2019
Q2 		$569K Sell
6,640
-525
-7% -$44.9K ﹤0.01% 836
2019
Q1 		$637K Sell
7,165
-41
-0.6% -$3.8K ﹤0.01% 1049
2018
Q4 		$613K Hold
7,206
– – ﹤0.01% 1031
2018
Q3 		$699K Buy
7,206
+147
+2% +$14.7K ﹤0.01% 1063
2018
Q2 		$665K Sell
7,059
-57,190
-89% -$5.01M ﹤0.01% 900
2018
Q1 		$5.21M Sell
64,249
-12,660
-16% -$1.09M 0.01% 437
2017
Q4 		$6.86M Sell
76,909
-21,130
-22% -$1.84M 0.02% 372
2017
Q3 		$9.12M Sell
98,039
-4,426
-4% -$391K 0.02% 303
2017
Q2 		$9.31M Sell
102,465
-8,700
-8% -$792K 0.02% 284
2017
Q1 		$9.76M Buy
111,165
+5,164
+5% +$459K 0.03% 277
2016
Q4 		$8.78M Buy
106,001
+8,558
+9% +$736K 0.02% 281
2016
Q3 		$9.02M Sell
97,443
-2,274
-2% -$214K 0.02% 273
2016
Q2 		$7.76M Buy
99,717
+25,600
+35% +$2.18M 0.02% 258
2016
Q1 		$6.11M Buy
74,117
+70,640
+2,032% +$5.75M 0.02% 271
2015
Q4 		$364K Hold
3,477
– – ﹤0.01% 668
2015
Q3 		$366K Buy
3,477
+300
+9% +$40.1K ﹤0.01% 608
2015
Q2 		$435K Hold
3,177
– – ﹤0.01% 596
2015
Q1 		$396K Hold
3,177
– – ﹤0.01% 621
2014
Q4 		$287K Buy
3,177
+1,545
+95% +$128K ﹤0.01% 665
2014
Q3 		$118K Sell
1,632
-2,031
-55% -$133K ﹤0.01% 755
2014
Q2 		$228K Sell
3,663
-20,000
-85% -$1.21M ﹤0.01% 747
2014
Q1 		$1.61M Sell
23,663
-2,634
-10% -$194K 0.01% 467
2013
Q4 		$1.85M Hold
26,297
– – 0.01% 450
2013
Q3 		$1.9M Sell
26,297
-60,000
-70% -$3.99M 0.01% 447
2013
Q2 		$4.82M Buy
+86,297
New +$5.38M 0.03% 285

Other funds holding BMRN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM

Nordea Investment Management's BMRN Position: Q2 2026 in Review

Nordea Investment Management increased its BioMarin Pharmaceuticals (BMRN) stake by 0.92% in Q2 2026, buying an estimated $57.6K and bringing the position to 114,953 shares worth $6.55M. The position accounts for 0.01% of the portfolio, ranked #552.

Nordea Investment Management first reported a position in BMRN in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.76M in Q1 2017. 228 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Nordea Investment Management held 114,953 shares of BioMarin Pharmaceuticals worth $6.55M as of Q2 2026.
  • Nordea Investment Management bought 1,051 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $57.6K.
  • BioMarin Pharmaceuticals made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #552 holding.
  • Nordea Investment Management first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Nordea Investment Management's BioMarin Pharmaceuticals position peaked at $9.76M in Q1 2017.
  • 228 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.